Clinical Trials Contact

About this Clinical Trial

Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)

Your Message Will Go To

Lisa Zhou

650-736-4112


All fields are required. *

Preferred contact method*

To:

Lisa Zhou

650-736-4112



Go Back To The Trial

We were not able to send your contact info at this time.

Go Back To The Trial

©2022 Stanford Medicine